Govt permits 6 companies to produce Covid-19 drug remdesivir
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
February 07, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, FEBRUARY 07, 2023
Govt permits 6 companies to produce Covid-19 drug remdesivir

Health

TBS Report
03 May, 2020, 08:30 pm
Last modified: 03 May, 2020, 08:52 pm

Related News

  • UNFPA and BRAC host knowledge dissemination event on Covid-19
  • The supply chain crisis opens door to resilience
  • Hong Kong says 'hello' to woo back visitors after Covid
  • US to end Covid-19 emergency declarations on 11 May
  • Covid remains a public health emergency, says WHO

Govt permits 6 companies to produce Covid-19 drug remdesivir

The six pharmaceutical companies that got the permission are -- Beximco, Beacon, Eskayef (SK-F), Incepta, Square and Healthcare

TBS Report
03 May, 2020, 08:30 pm
Last modified: 03 May, 2020, 08:52 pm
File Photo: Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. Picture taken March 18, 2020. Gilead Sciences Inc/Handout via Reuters
File Photo: Vials of investigational coronavirus disease (Covid-19) treatment drug remdesivir are capped at a Gilead Sciences facility in La Verne, California, US March 18, 2020. Picture taken March 18, 2020. Gilead Sciences Inc/Handout via Reuters

The Directorate General of Drug Administration has given permission to six pharmaceutical companies to produce the potential Covid-19 drug "remdesivir".

The companies are -- Beximco, Beacon, Eskayef (SK-F), Incepta, Square and Healthcare. 

The Drug Administration gave permission considering the current coronavirus situation in the country, Assistant Director Mohammad Salahuddin told The Business Standard.

A drug administration official, unwilling to be named, said that SK-F and Beximco are going to start the production after importing the raw materials within this month. 

But the decision on - when the medicines will be sent to the hospitals - is yet to be made. The decision will come after the trial of the medicine. 

Remdesivir is being used on Covid-19 patients in several countries including the US. It has a history to work well against the SARS and Ebola virus.

Bangladesh / Top News / Covid-19 in Bangladesh

remdesivir / COVID-19 / Coronavirus

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • A general view shows damaged and collapsed buildings after an earthquake in Kahramanmaras, Turkey February 6, 2023. Ihlas News Agency (IHA) via REUTERS
    Deaths exceed 4,300 as catastrophic quakes ravage Turkey, Syria
  • 30% cos see double-digit growth even in hard times
    30% cos see double-digit growth even in hard times
  • Each Reverse Osmosi plant can produce approximately 8,000 litres of drinking water a day for around 250 families. Photo: Sadiqur Rahman
    A drop in the ocean of persistent water crisis

MOST VIEWED

  • Photo: Courtesy
    UNFPA and BRAC host knowledge dissemination event on Covid-19
  • LC issues lead to severe shortage of surgical equipment
    LC issues lead to severe shortage of surgical equipment
  • Photo: TBS
    All the districts now at risk of Nipah virus: IEDCR
  • Major Nipah outbreak feared as infections hit eight-year high
    Major Nipah outbreak feared as infections hit eight-year high
  • Illustration: TBS
    Woes of cancer care: Scarce treatment facilities keep patients wait for months
  • Photo: TBS
    32 districts at risk of Nipah virus: DGHS

Related News

  • UNFPA and BRAC host knowledge dissemination event on Covid-19
  • The supply chain crisis opens door to resilience
  • Hong Kong says 'hello' to woo back visitors after Covid
  • US to end Covid-19 emergency declarations on 11 May
  • Covid remains a public health emergency, says WHO

Features

Nimah designed by Compass Architects- Wooden tiles. Photo: Junaid Hasan Pranto

Trendy flooring designs to upgrade any space

48m | Habitat
Benefits of having high ceilings in your new home

Benefits of having high ceilings in your new home

18m | Habitat
Each Reverse Osmosi plant can produce approximately 8,000 litres of drinking water a day for around 250 families. Photo: Sadiqur Rahman

A drop in the ocean of persistent water crisis

1h | Panorama
Photo: Collected

Get your partner a lovely present this Valentine's Day

1d | Brands

More Videos from TBS

Who will survive? Adani or Hindenburg?

Who will survive? Adani or Hindenburg?

15h | TBS Stories
James Gunn’s 8-10-year plan for the DC Universe

James Gunn’s 8-10-year plan for the DC Universe

15h | TBS Entertainment
LC issues lead to severe shortage of surgical equipment

LC issues lead to severe shortage of surgical equipment

18h | TBS Insight
Stage plays are going on in the digital age

Stage plays are going on in the digital age

23h | TBS Stories

Most Read

1
Photo: Courtesy
Panorama

From 'Made in Bangladesh' to 'Designed in Bangladesh'

2
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

3
Master plan for futuristic Chattogram city in the making
Districts

Master plan for futuristic Chattogram city in the making

4
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

5
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

6
Photo: Collected
Crime

Prime Distribution MD Mamun arrested in fraud case

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]